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Autophagy participates in multiple fundamental physiological processes, including survival, differentiation, development, and
cellular homeostasis. It eliminates cytoplasmic protein aggregates and damaged organelles by triggering a series of events:
sequestering the protein substrates into double-membrane vesicles, fusing the vesicles with lysosomes, and then degrading the
autophagic contents. This degradation pathway is also involved in various disorders, for instance, cancers and infectious diseases.
This paper provides an overview of modulation of autophagy in the course of reovirus infection and also the interplay of autophagy
and reovirus.
1. Introduction
Autophagy is a cellular degradation process by which cyto-
plasmic substrates are processed for lysosomal degradation.
In eukaryotic cells, two types of autophagy are involved
in dynamic rearrangement of the sequestering membrane,
namely, microautophagy and macroautophagy. Microau-
tophagy involves the engulfment of cytoplasm directly at
the surface of lysosome by invagination, protrusion, and
septation of the lysosomal limiting membrane [1]. In this
review, we focus on macroautophagy, hereafter referred to
as autophagy. In general, the process of autophagy begins by
double-membrane initiation, followed by cargo recognition,
and fusion with lysosomes (autophagosomematuration) that
results in cargo degradation (Figure 1). The membrane of
autophagosomes is derived from the plasma membrane and
cellular organelles. After cytoplasmic material (the cargo)
is sequestered in cup-shaped double-membrane structures
(phagophores), the edges of the membranes are then sealed
and the formation of autophagosomes is complete. By traf-
ficking along microtubules, autophagosomes migrate to the
proximity of lysosomes for fusion. Subsequently, autophagic
cargos containing cytosolic constituents are degraded by
lysozyme activity [2].This process will eliminate intracellular
pathogens and damaged organelles which are too large for
the proteasome, resulting in the recycling of nutrients and the
generation of energy [3].
Autophagy is regulated by several cellular signaling
pathways, class I phosphoinositide 3-kinase (PI3K)-protein
kinase B (PKB)-mammalian target of rapamycin complex
1 (mTORC1), and other mTOR-independent pathways, for
instance, cyclical Ca2+-calpain-G𝛼s and cAMP-Epac-PLC-𝜀-
IP3 and the basic helix-loop-helix leucine zipper transcrip-
tion factor EB (TFEB)-mediated pathway [2] (Figure 1). The
biogenesis of autophagosomes requires more than fifteen
autophagy-related (Atg) proteins, including class III PI3Ks,
UNC51-like kinase 1 (ULK1) complex, and microtubule-
associated protein 1 light-chain 3 (LC3) that act on different
modules. These Atg proteins are sequentially recruited at
the phagophore assembly site. For instance, ULK1 and PI3K
complexes (composed of Beclin-1 and class III PI3K etc.)
congregate at the phagophore assembly site for initiating
autophagy. And the proteins Atg8 and LC3 are involved in
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Figure 1: Regulation of autophagy by ARV.The autophagy process contains several distinct steps, including membrane isolation, nucleation,
vesicle formation, fusion of autophagosome with lysosome, and degradation of the cargo followed by release of the degradation products
back into the cytosol.The activity of autophagy is regulated by several cellular signaling pathways; mTOR-dependent pathway (via mTORC1),
and mTOR-independent pathways (such as TFEB-mediated pathway and cyclical Ca2+-calpain-G𝛼s and cAMP-Epac-PLC-𝜀-IP3 pathways).
Starvation inhibits mTORC1, a downregulator of autophagy, and also induces dephosphorylation of TFEB resulting in the activation of
autophagy [2]. Infection of ARV promotes autophagy via the action of p17 protein at the various steps of PI3K-Akt-mTORC1 pathway and
also on activation of PKR/eIF2𝛼 signaling [9]. In the case of Beclin-1 regulation, Wirawan et al. demonstrated that caspase activation in cells
undergoing autophagy has been demonstrated to cleave Beclin-1, thereby inducing apoptosis [10]. The antiapoptotic protein, Bcl-2, interacts
with Beclin-1 and inhibits Beclin 1-dependent autophagy [11]. Autophagy and apoptosis are basic cellular pathways that are regulated by
JNK-mediated Bcl-2 phosphorylation [12]. JNK1-mediated Bcl-2 phosphorylation interferes with its binding to Beclin-1, thereby promoting
autophagy induction [12]. More recently, a report by Wang et al. demonstrated that Akt-mediated phosphorylation of Beclin-1 increased its
interactions with 14-3-3 and vimentin, leading to autophagy inhibition [13].
the expansion and fusion of phagophore edges and can recruit
adaptor proteins to autophagosomes [4].
Autophagy has been considered to be a stress response
that allows eukaryotic organisms to survive during harsh
conditions, such as nutrient starvation, energy depletion [5],
or reactive oxygen stress [6]. Under starvation conditions,
the induction of autophagy degrades proteins, carbohydrates,
and lipids that allow the cell to maintain energy levels; this
adaptation has been shown to be important for survival
during neonatal starvation in mice, for example, [7]. In addi-
tion, inhibition of autophagy accelerates starvation-induced
apoptosis, indicating that autophagy machinery exerts a
crucial role under conditions of nutrient deprivation [8].
It has been demonstrated that autophagy is also acti-
vated by many pathogens and contributes to host defenses
confronting microbial infection. In the past decade, the
mechanisms by which viruses either subvert or enhance
autophagy in their replication and pathogenesis have been
intensively studied [3, 14, 15]. In this review, we describe
recent research findings which examine the modulation of
autophagy by mammalian reovirus (MRV) and by avian
reovirus (ARV), as well as the autophagy signalingmodulated
by other viral proteins.
Reovirus, named for respiratory, enteric, and orphan,
belongs to genus Orthoreovirus in family Reoviridaeand is a
nonenveloped virus with a genome consisting of 10 double-
stranded RNA segments. Reovirus has a wide host range,
from reptiles to birds to mammals. In general, reovirus
infections in humans are asymptomatic andmostly restricted
to the upper respiratory and gastrointestinal tracts [16].While
reovirus is not a significant human pathogen, interestingly,
MRV has the ability to preferentially kill a variety of tumor
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cells (both in vivo and in vitro) by oncolysis, particularly
MRV type 3 (strain Dearing), which has led to its use as a
cancer treatment in several different clinical trials, including
head and neck tumors [17], and more recently multiple
myeloma [18]. In addition, it is clear that apoptosis plays a
role in reovirus oncolysis. However, the interplay between
autophagy and apoptosis which leads to oncolysis in MRV
infection remains largely unknown.
2. Viral Induction of Autophagy in Oncolysis
Several lines of evidence have shown that MRV selectively
replicates in cells with activated Ras signaling pathways [19–
21]. In fact, cells that are resistant to reovirus become sus-
ceptible either by the introduction of constitutively activated
epidermal growth factor receptor (v-erbB oncogene) which
activates Ras [20] or by introduction of active Ras [22].
Ras is a protooncogene that encodes a key regulator of
mitogenic signals. Reoviruses, while they can infect a wide
variety of cells from various hosts, selectively cause lysis
in transformed cells with aberrant signaling pathways and
have been demonstrated to target multiple cancers, including
multiple myeloma [23–25].
Multiple myeloma (MM) is a neoplasm of plasma cell
origin and accounts for ∼10% of all blood cell malignancies
[26]. Mutations of N-Ras or K-Ras resulting in constitutive
activity have been identified in myeloma with a frequency
approaching 50% [27, 28]. In addition to activation of
Ras pathway, multiple myeloma has been characterized by
the activation of several other signaling pathways which
promote tumorogenesis, for instance, MEK/ERK, PI3K/Akt,
mTOR/p70S6 kinase, and NF-𝜅B pathways [23–25]. These
activated pathways may increase the lytic infection efficiency
of MRV which suggested that reovirus may be an effective
alternative therapy forMM.Oncolytic viruses are very attrac-
tive cancer therapies since they replicate and may continue
to spread and infect more tumor cells. MRV has been
demonstrated to target and kill MM, and a phase I clinical
trial has recently been initiated [18, 29]. Thirukkumaran et
al. demonstrated that apoptosis induced by MRV infection
contributes to oncolysis of human multiple myeloma cell
lines (HMCL) [30]. In addition to apoptosis, the formation of
cellular autophagosome puncta containing LC3-II, indicating
activation of autophagy, was detected in myeloma cells at 24–
48 hours after infection of live reovirus and this autophagy
activation was further blocked by autophagy inhibitor 3-
methyladenine (3-MA) [18].
While the role of autophagy in MRV-induced cell death
has not yet been characterized, recent studies of other
oncolytic viruses (OV), such as adenovirus and human
simplex virus (HSV), may shed some light on this question.
Infection of melanoma cells with a HSV type 2 mutant
(ΔPK) containing a deletion of the ICP10 gene (encoding a
viral protein kinase) reduced the melanoma tumor burden
via activation of a number of functionally distinct proteases
(caspase-3, caspase-7, and calpain) and also via upregulation
of the proapoptotic protein H11/HspB8, as well as Beclin-1
[31], a critical autophagy protein that has been shown to be
a potent suppressor of human brain tumours andmelanomas
[32, 33]. These results demonstrated that the ΔPK virus-
induced oncolytic activity is involved in nonredundant virus-
induced programmed cell death (PCD) pathways, including
apoptosis and autophagy processes.
Adenoviruses (Ads) deficient in E1b function, like
reoviruses, can selectively replicate in and cause oncolysis of
cancer cells [34]. In a study using a series of Ads, Rodriguez-
Rocha et al. demonstrated that both wild-type (Ad5) and
E1b-deleted (Adhz60) adenoviruses induce autophagosome
formation as evidenced by the enhanced incorporation of
LC3-II to autophagosomes and the formation of the Atg12–
Atg5 complexes in a human lung cancer cell line (A549) [35].
However, deletion of both E1a and E1b (which abolishes viral
replication) failed to activate formation of autophagosomes.
3-MA treatment of cells infected with either Ad5 or Adhz60
not only inhibited autophagy, but also decreased the accumu-
lation of viral proteins as well as the yield of virus progeny.
These findings indicate that autophagy induced by aden-
ovirus correlates positively with virus infection. Conversely,
Botta et al. proposed that autophagy acts as a cell survival
response: despite observing the activation of autophagy in
glioma cells infected with dl922-947, a replication compe-
tent oncolytic Ad with a 24-bp deletion in E1a conserved
region-2, they found that, paradoxically, the main negative
regulator of autophagy (the Akt/mTOR/p70s6k pathway) was
activated and the positive regulator (the ERK1/2 pathway)was
inhibited during Ad viral infection [36]. Moreover, inhibition
of autophagic pathways by either 3-MA or chloroquine
increased the replication and cytotoxicity of the dl922-947
virus, indicating that autophagy might play a survival and/or
defensive role in glioma cells infected by oncolytic Ads with
E1a-deficiencies. Since different Ad viruses were tested on
different cancer cells in each of these studies, the interplay
between autophagy and viral infections is likely complicated;
the activation of autophagy and its subsequent effect aremost
likely dependent on virus and cell type.
3. Avian Reovirus Modulates the Host
Autophagy Pathway
Recently, Meng and his colleagues demonstrated that ARV
S1133 strain induces autophagy in both primary chicken
embryonic fibroblast (CEF) cells andmammalian cells (Vero)
by showing that virus infection increased the number of
double-membrane vesicles, dots of GFP-LC3 (from transient
expression), and the elevated production of the autophagy
indicator, LC3-II [47]. They also demonstrated that ARV
infection triggers autophagy through PI3K/Akt/mTOR path-
way [47]. However, the detailed mechanism by which ARV
triggers the autophagy pathway was not revealed until
recently; Chi et al. demonstrated that ARV nonstructural
protein p17 functions as an activator of autophagy [9]. In
the presence of ARV protein p17, expression levels of Beclin-
1 and LC3-II were increased [9] (Figure 1). Moreover, ARV
protein p17 was found to regulate p53/PTEN/mTOR and
adenosinemonophosphate-activated protein kinase (AMPK)
and led to downregulation of the key negative regulator
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Table 1: The target of viral proteins on modulators of autophagy.
Virus Viral protein Direct target Downstream# References
Hepatitis C virus Nonstructural protein 4B(NS4B) Rab5 (early endosome, complex to PI3K) None [37]
Hepatitis C virus NS4B Vps34 (PI3K complex) PIP3/Akt [37]
Rotavirus NSP4 Calcium/calmodulin-dependent proteinkinase kinase 2 (CAMKK2) AMPK [38]
Rotavirus NSP4 5
󸀠 adenosine monophosphate-activated
protein kinase (AMPK) TSC1/2 [39]
Herpes simplex virus type 1 (HSV-1) ICP34.5 Beclin-1 LC3-II [40]
Simian virus 40 Small T antigen AMPK mTOR [41]
ARV p17 p53 PTEN [9]
ARV p17 AMPK mTORC1 [9]
ARV p17 PKR/eIF2𝛼 Beclin-1 [9]
Hepatitis B virus HBV X protein (HBx) Phosphatidylinositol 3-kinase class III(PI3KC3) mTOR [42]
KSHV, HVS, and MCV∗ viral FLIP Atg3 LC3 [43–45]
CHIKV and SINV NSP4 eIF2𝛼 ATF-4 [46]
Note: ∗Kaposi’s sarcoma-associated herpesvirus (KSHV), herpesvirus saimiri (HVS), molluscum contagiosum virus (MCV).
#Downstream effect on autophagy resulted from the interaction of viral proteins with their direct targets.
mTOR, which in turn induces autophagy. In addition, ARV
also activates the PKR/eIF2𝛼 pathway that has been shown
to promote autophagy [9]. A previous report by Talloczy et
al. also suggested that virus induced autophagy by the eIF2
alpha kinase signaling pathway [48]. Furthermore, this team
discovered that ARV triggered AMPK signaling facilitates
activation of theMKK 3/6 andMAPK p38 signaling pathway,
which is beneficial for ARV replication [49].
In addition to ARV, accumulating lines of evidence have
suggested that several other viruses-induced autophagies play
important roles in the viral life cycles and pathogenesis.
Human tumor viruses (𝛾-herpesviruses) Epstein-Barr virus
(EBV) andKaposi’s sarcoma-associated herpesvirus (KSHV),
hepatitis C virus (HCV), rotavirus, and hepatitis B virus
(HBV) have evolved various strategies to either subvert
or enhance autophagy pathway for their replication and
pathogenesis (Table 1).
In the course of ARV infection, activation of autophagy
with rapamycin increased yield of ARV, while inhibition
of the autophagosomal pathway by chloroquine treatment
resulted in a decrease in virus production [47]. Consistent
with this, suppression of autophagic proteins (Beclin-1, Atg7,
and LC3) that are responsible for autophagosome formation
by means of shRNA strategy or inhibitor (MA-3) led to
a reduced viral transcription and/or ARV replication [9].
Furthermore, knockdown of expression of either LAMP2 or
Rab7a, the two proteins required for the fusion of autophago-
somes with lysosomes [50], significantly decreased virus
replication; these results indicate that autophagy facilitates
the propagation of ARV. A similar phenomenon has been
observed with other viruses, such as hepatitis C virus [37]
and rotavirus [39], and simian virus 40 (SV40) [41], where
viral nonstructural proteins induced autophagywhich in turn
increased either viral replication or cell survival.
Rotavirus activates calcium-mediated signaling path-
way and AMPK to trigger autophagy [39]. NSP4, a pore-
forming protein (viroporin), activates a calcium signal-
ing pathway by eliciting the release of calcium from the
lumen of endoplasmic reticulum (ER) into the cytoplasm
in the rotavirus infected cell. Consequently, the cytoplas-
mic calcium triggered a calcium signaling pathway involv-
ing calcium/calmodulin-dependent protein kinase kinase
2 (CAMKK2) and AMPK to activate autophagy that was
then utilized for trafficking viral protein and facilitate virus
replication. SV40 small T antigen also inactivates PP2A to
activate AMPK that enables survival of cancer cells under
glucose deprivation via the inhibition of protein synthesis
and activation of autophagy as an alternative energy source
[41]. Dreux et al. reported that accumulation of autophagic
vesicles and conversion of endogenous LC3 to LC3 II were
increased in HCV-infected cells [51]. Similarly the activation
of autophagy machinery is required for distinct stages of
HCV infection, such as delivery of incoming viral RNA to
the translation apparatus, initiation of HCV replication, and
viral spread, but not required once the infection is established
[51]. Recently, several HCV proteins have been demonstrated
to be responsible for induction of autophagy [37, 52]. HCV
NS5A is sufficient to promote autophagosome formation
by enhancing promoter activity and protein expression of
Beclin-1 [52]. In addition to NS5A, NS4B can form a complex
with Rab5 and Vps34 resulting in increased autophagic
vesicle formation [37].
Previous study suggested that herpes simplex virus type
1 (HSV-1)-encoded ICP34.5 binds to the autophagy protein
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Beclin-1 and inhibits Beclin-1 [40]. Upon autophagy initia-
tion, Beclin-1 forms an activating complex with the class III
PI3 kinase Vps34 for vesicle nucleation [53], so when ICP34.5
binds Beclin-1, it inhibits cellular autophagy. It was reported
that KSHV (a 𝛾-herpesvirus) has evolved strategies to inter-
ferewith various aspects of autophagosome formation:KSHV
counteracts autophagy initiation by encoding a viral Bcl-2
homolog that strongly binds toBeclin-1 and acts as a repressor
of autophagic vesicle nucleation [54, 55]. In addition, another
viral protein, vFLIP, blocks autophagosome formation by
binding to Atg3, thereby preventing LC3 processing [56]. In
contrast to KSHV, it was found that binding of HBx protein
of HBV with Vps34 stimulates autophagy induction [42].
4. Reovirus and Apoptosis
Cell death has been generally classified into two groups,
apoptosis and necrosis. However, Clarke classified PCD into
four types [57]: type I cell death (also called classical apoptotic
cell death), type II cell death (or autophagic cell death),
type III cell death (also called necrosis-like programmed cell
death) defined as nonlysosomal vesicle degradation, and the
other type of PCD that is unfortunately poorly understood.
In any case, type II cell death and type III cell death seem to
operate in a caspase-independent manner [58].
Very recently, crosstalk between apoptosis and autophagy
has been proposed [59, 60]. Beclin-1, the major protein
responsible for autophagy, has been demonstrated to interact
with a number of proteins; it is worth noting that, in addition
to autophagic proteins, Bcl-2 (known as an antiapoptotic pro-
tein) binds with Beclin-1 to functionally antagonize Beclin-
1-mediated autophagy [61, 62]. Another apoptosis related
protein, caspase-8, also participates in autophagy: caspase-
8 activation during apoptosis can cleave Beclin-1 and lead
to a decrease in autophagy [63]. These findings indicate the
possibility that viral protein(s) might modulate the switch
between autophagy and apoptosis to facilitate their own
replication.
The mechanisms of ARV-induced apoptosis and its
signaling pathways in cultured cells have been extensively
explored [64–69]. A previous study revealed that ARV
infection upregulated p53 via multiple pathways including
Src, Ras, and PKC 𝛿 [66]. Activation of p53 leads to induction
of Bax and Bax translocation from cytosol to mitochondria
at middle to late stage of ARV infection (after 18 hour post
infection, hpi). Moreover, activation of caspases-9 and -3
was also detected in ARV-infected BHK-21 cells, indicating
that ARV-induced apoptosis was accomplished by a caspase-
dependentmechanism. Interestingly, significant syncytia for-
mation in ARV-infected BHK-21 cells was observed undergo-
ing apoptosis, establishing a correlation between ARV virus
replication and apoptosis in cultured cells [64].
It has been demonstrated that ARV protein 𝜎C serves as
an apoptosis inducer [67].Overexpression ofARVprotein𝜎C
resulted in the upregulation of p53 and triggered apoptosis.
Further investigation demonstrated that ARV infection or
in the presence of 𝜎C by itself caused apoptosis mediated
through the DNA damage signaling pathway, as evidenced by
upregulation of two DNA-damage-responsive genes, DDIT-3
and GADD45𝛼 [68].
Interestingly, ARV proteins p17 and 𝜎C responsible for
induction of autophagy and apoptosis, respectively, colocalize
well with the autophagy indicator LC3, although neither
ARV protein p17 nor 𝜎C physically interacted with LC3
[9]. A previous study indicated that ARV triggers Akt at
early time of infection (2 hpi), resulting in delayed apoptosis
[69]. Considering that ARV induces cell death in the middle
to late stages of infection [69], it is possible that ARV
triggers survival signaling that protects the host cells from
caspase-dependent apoptosis and benefits the progression of
viral infection at the early stage of infection. However, the
precise mechanism that ARV participates to switch between
autophagy and apoptosis requires further investigation.
The ability of MRV to activate apoptosis depends on the
different serotypes of viruses introduced to a host cell. MRV
type 3 has previously been shown to trigger apoptosis more
strongly than MRV type 1, and this difference mapped to the
viral gene segments S1 and M2 [70]. These gene segments
encode capsid proteins sigma 1 and mu 1, respectively. Sigma
1 is the major viral attachment protein, but it has also been
shown in MRV type 3 to trigger reovirus-induced apoptosis
through its binding to sialic acid on cell lines, which leads
to activation of NF-𝜅B [71]. Previous work has demonstrated
that viral mu1 protein alone can stimulate apoptosis in
transfected cell lines, with MRV type 3 mu1 eliciting more
caspase-3 activation than MRV type 1 mu1 [72]. Danthi et
al. have shown that certain mutations in mu 1 from MRV
type 3 result in a great reduction in virus-induced apoptosis
in cell lines at high multiplicities of infection (MOI), which
stems from a failure to adequately activate the proapoptotic
transcription factors NF-𝜅B and IFR-3 [73].
MRV-induced apoptosis in cell lines may also be
enhanced by soluble tumor necrosis factor-related apoptosis
inducing ligand (TRAIL), released by MRV infected cells,
which binds to death receptors (DR) 4, and DR5 found on
the cell surface [74]. DR4 and DR5 signaling in certain types
of reovirus infected cells results in the activation of caspase-
8, which then activates downstream caspases [75]. In some
cells, reovirus-induced apoptosis is dependent on caspase-
8, as caspase-8 inhibitors block apoptosis [74]. Reovirus
infection also results in the activation of many apoptotic
effectors, including other caspases, JNK and c-Jun, calpain,
Bid cleavage, and Smac/DIABLO [76]. Whether and how
MRV-induced apoptosis connects to autophagy at this stage
remains largely unknown.
5. Conclusions and Discussion
Undoubtedly, there are multiple mechanisms that different
viruses exploit to modulate autophagy in their host cells,
presumably to their replicative advantage. Autophagy clearly
plays an important role in ARV replication [9]. ARV pro-
tein p17 induces autophagy by its action on three differ-
ent pathways: p17 activates two pathways AMPK and the
tumor suppressor PTEN that in turn block the activation of
mTORC1, themajor inhibitor of autophagy [9]. Furthermore,
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p17 induces PKR and eIF2𝛼 phosphorylation that lead to host
translation shutoff and also to activating autophagy [9]. In
contrast to ARV, the viral protein responsible for modulation
of autophagy in MRV remain unexplored.
Ideally, an oncolytic virus used in cancer therapy repli-
cates well in order to spread to and kill tumor cells more
efficiently, as has been suggested [35]. Autophagy seems
to contribute to MRV replication, although its tie to viral
replication has not been shown directly as it has been in ARV
infection. MRV replicates better in cells that have intact PKR
pathways [77], suggesting that autophagy may enhanceMRV
replication.
MRV induces both autophagy and apoptosis in tumour
cells; what is not known is whether and to what extent
autophagy is ultimately responsible for tumour death by
reoviruses. InMRV-infected transformed cells, apoptosis also
contributes to viral oncolytic activity [78]. In fact, MRV type
3 (Dearing) has been the preferred clinically used oncolytic
mammalian reovirus, and it has been shown to induce
apoptosis more robustly than MRV type 1 (Lang), though
their replication rates are very similar [70]. This leads to the
question of whether autophagy and apoptosis are induced
by the same upstream signals in infected cells or by distinct
mechanisms. Since different ARV proteins are responsible
for activating autophagy and apoptosis, it may be that MRV
also activates these pathways through separate mechanisms.
It is possible that reovirus simply induces autophagy and
apoptosis sequentially, but not hierarchically. The sequential
activation is supported by previous findings [9, 47, 69]. If
there is no hierarchy between autophagy and apoptosis, then
as suggested by Maiura et al. inhibition of apoptosis might
lead to either cell survival or necrosis (depending on the
outcome of autophagy) without affecting autophagy, and
inhibition of autophagy may likewise not affect apoptosis
[60]. Berger and Danthi observed that MRV-infected L929
cells treated with caspase inhibitors do die, but by a receptor
interacting protein 1 (RIP1) kinase pathway that results in a
type of cell death known as necroptosis, the programmed
necrosis triggered by death receptor signaling [79]. Cells
undergoing necroptosis also undergo extensive autophagy,
which some believe is the major mechanism for cell death
by necroptosis [80]. Therefore, the caspase-independent cell
death pathway activated in MRV-infected cells may in fact be
mediated by virus-induced autophagy. It would likewise be
very helpful to determine if inhibition of autophagy in MRV-
infected cells has any effect on apoptosis.
It seems possible, though, that apoptosis induction may
shift the cell away from autophagy and autophagy-induced
death in reovirus infections. Caspase activation in cells
undergoing autophagy has been shown to cleave Beclin-1,
which can then no longer interact with autophagosomes,
but instead the cleaved protein interacts with mitochondria,
promoting apoptosis [10]. ARV infection and p17 transfection
of immortalized chicken embryo fibroblast (DF-1) and Vero
cells both lead to an increase in Beclin-1 by 24 hpi [9],
however, whether that goes down during peak times of ARV-
induced apoptosis, as well as whether the cleaved Beclin-1
product is detectable, has not been determined yet. It will
be very interesting in the future to clarify the connections
between autophagy and apoptosis in reovirus infections.
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